Comparative Evolution of GII.3 and GII.4 Norovirus over a 31-Year Period

被引:125
|
作者
Boon, Denali
Mahar, Jackie E. [2 ,3 ]
Abente, Eugenio J.
Kirkwood, Carl D. [2 ]
Purcell, Robert H.
Kapikian, Albert Z.
Green, Kim Y.
Bok, Karin [1 ]
机构
[1] NIAID, Caliciviruses Sect, Infect Dis Lab, NIH,DHHS, Bethesda, MD 20892 USA
[2] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic, Australia
[3] La Trobe Univ, Bundoora, Vic 3086, Australia
基金
美国国家卫生研究院;
关键词
AUTOMATED PROTEIN-STRUCTURE; ACUTE GASTROENTERITIS; SEQUENCE-ANALYSIS; NORWALK VIRUS; I-TASSER; INFECTION; OUTBREAK; CHILDREN; MODEL; PERSISTENCE;
D O I
10.1128/JVI.00472-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Noroviruses are the most common cause of epidemic gastroenteritis. Genotype II.3 is one of the most frequently detected noroviruses associated with sporadic infections. We studied the evolution of the major capsid gene from seven archival GII.3 noroviruses collected during a cross-sectional study at the Children's Hospital in Washington, DC, from 1975 through 1991, together with capsid sequence from 56 strains available in GenBank. Evolutionary analysis concluded that GII.3 viruses evolved at a rate of 4.16 x 10(-3) nucleotide substitutions/site/year (strict clock), which is similar to that described for the more prevalent GII.4 noroviruses. The analysis of the amino acid changes over the 31-year period found that GII.3 viruses evolve at a relatively steady state, maintaining 4% distance, and have a tendency to revert back to previously used residues while preserving the same carbohydrate binding profile. In contrast, GII.4 viruses demonstrate increasing rates of distance over time because of the continued integration of new amino acids and changing HBGA binding patterns. In GII.3 strains, seven sites acting under positive selection were predicted to be surface-exposed residues in the P2 domain, in contrast to GII.4 positively selected sites located primarily in the shell domain. Our study suggests that GII.3 noroviruses caused disease as early as 1975 and that they evolve via a specific pattern, responding to selective pressures induced by the host rather than presenting a nucleotide evolution rate lower than that of GII.4 noroviruses, as previously proposed. Understanding the evolutionary dynamics of prevalent noroviruses is relevant to the development of effective prevention and control strategies.
引用
收藏
页码:8656 / 8666
页数:11
相关论文
共 50 条
  • [21] Serological Correlates of Protection against a GII.4 Norovirus
    Atmar, Robert L.
    Bernstein, David I.
    Lyon, G. Marshall
    Treanor, John J.
    Al-Ibrahim, Mohamed S.
    Graham, David Y.
    Vinje, Jan
    Jiang, Xi
    Gregoricus, Nicole
    Frenck, Robert W.
    Moe, Christine L.
    Chen, Wilbur H.
    Ferreira, Jennifer
    Barrett, Jill
    Opekun, Antone R.
    Estes, Mary K.
    Borkowski, Astrid
    Baehner, Frank
    Goodwin, Robert
    Edmonds, Anthony
    Mendelmank, Paul M.
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2015, 22 (08) : 923 - 929
  • [22] GII.4 Human Norovirus: Surveying the Antigenic Landscape
    Mallory, Michael L.
    Lindesmith, Lisa C.
    Graham, Rachel L.
    Baric, Ralph S.
    [J]. VIRUSES-BASEL, 2019, 11 (02):
  • [23] Norovirus Variant GII.4/Sydney/2012, Bangladesh
    Rahman, Mustafizur
    Nahar, Shamsun
    Afrad, Mokibul Hassan
    Faruque, Abu S. G.
    Azim, Tasnim
    [J]. EMERGING INFECTIOUS DISEASES, 2013, 19 (08) : 1347 - 1348
  • [24] The emergence and evolution of the novel epidemic norovirus GII.4 variant Sydney 2012
    Eden, John-Sebastian
    Hewitt, Joanne
    Lim, Kun Lee
    Boni, Maciej F.
    Merif, Juan
    Greening, Gail
    Ratcliff, Rodney M.
    Holmes, Edward C.
    Tanaka, Mark M.
    Rawlinson, William D.
    White, Peter A.
    [J]. VIROLOGY, 2014, 450 : 106 - 113
  • [25] Molecular Evolution of GII.P31/GII.4_Sydney_2012 Norovirus over a Decade in a Clinic in Japan
    Ushijima, Hiroshi
    Hoque, Sheikh Ariful
    Akari, Yuki
    Pham, Ngan Thi Kim
    Phan, Tung
    Nishimura, Shuichi
    Kobayashi, Masaaki
    Sugita, Kumiko
    Okitsu, Shoko
    Komoto, Satoshi
    Thongprachum, Aksara
    Khamrin, Pattara
    Maneekarn, Niwat
    Hayakawa, Satoshi
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [26] Identification of Human Norovirus GII.3 Blockade Antibody Epitopes
    Yi, Yufang
    Wang, Shuxia
    Wang, Xiaoli
    Xiong, Pei
    Liu, Qingwei
    Zhang, Chao
    Yin, Feifei
    Huang, Zhong
    [J]. VIRUSES-BASEL, 2021, 13 (10):
  • [27] Human norovirus GII.4 Hong Kong variant shares common ancestry with GII.4 Osaka and emerged in Thailand in 2016
    Chuchaona, Watchaporn
    Chansaenroj, Jira
    Puenpa, Jiratchaya
    Khongwichit, Sarawut
    Korkong, Sumeth
    Vongpunsawad, Sompong
    Poovorawan, Yong
    [J]. PLOS ONE, 2021, 16 (08):
  • [28] Epidemiological and molecular analysis of a waterborne outbreak of norovirus GII.4
    Zhou, X.
    Li, H.
    Sun, L.
    Mo, Y.
    Chen, S.
    Wu, X.
    Liang, J.
    Zheng, H.
    Ke, C.
    Varma, J. K.
    Klena, J. D.
    Chen, Q.
    Zou, L.
    Yang, X.
    [J]. EPIDEMIOLOGY AND INFECTION, 2012, 140 (12): : 2282 - 2289
  • [29] Immunogenetic Mechanisms Driving Norovirus GII.4 Antigenic Variation
    Lindesmith, Lisa C.
    Beltramello, Martina
    Donaldson, Eric F.
    Corti, Davide
    Swanstrom, Jesica
    Debbink, Kari
    Lanzavecchia, Antonio
    Baric, Ralph S.
    [J]. PLOS PATHOGENS, 2012, 8 (05)
  • [30] Comparative Efficacy of Seven Hand Sanitizers against Murine Norovirus, Feline Calicivirus, and GII.4 Norovirus
    Park, Geun Woo
    Barclay, Leslie
    Macinga, David
    Charbonneau, Duane
    Pettigrew, Charles A.
    Vinje, Jan
    [J]. JOURNAL OF FOOD PROTECTION, 2010, 73 (12) : 2232 - 2238